首页> 外国专利> USE OF GINKGO TERPENE LACTONE IN PREPARING DRUG FOR PREVENTING AND/OR TREATING GUILLAIN-BARRÉ-STROHL SYNDROME

USE OF GINKGO TERPENE LACTONE IN PREPARING DRUG FOR PREVENTING AND/OR TREATING GUILLAIN-BARRÉ-STROHL SYNDROME

机译:银杏萜内酯在制备用于预防和/或治疗吉兰-巴雷-斯特劳综合征的药物中的用途

摘要

A use of ginkgo terpene lactone in preparing a drug for preventing and/or treating Guillain-Barré-Strohl syndrome. Ginkgo terpene lactone has certain effects on relieving the condition of EAN mice, and the use of a combination of different ginkgo terpene lactone monomer compounds shows a certain synergistic effect. Ginkgo terpene lactone can be used clinically to prevent and/or treat the symptoms of Guillain-Barré-Strohl syndrome, and no adverse reactions have been observed. The means of of obtaining the medical raw materials is common, preparation costs are lower, the costs of patient treatment are low, and safety is high.
机译:银杏萜内酯在制备用于预防和/或治疗格林-巴利-斯特罗尔综合症的药物中的用途。银杏萜烯内酯对缓解EAN小鼠的病情有一定的作用,不同银杏萜烯内酯单体化合物的组合使用具有一定的协同作用。银杏萜内酯可在临床上用于预防和/或治疗Guillain-Barré-Strohl综合征的症状,并且未观察到不良反应。获得医疗原料的方法是普遍的,制备成本较低,患者治疗成本较低,安全性较高。

著录项

  • 公开/公告号WO2020207398A1

    专利类型

  • 公开/公告日2020-10-15

    原文格式PDF

  • 申请/专利权人 CHENGDU BAIYU PHARMACEUTICAL CO. LTD.;

    申请/专利号WO2020CN83678

  • 发明设计人 LI HUIQIN;TANG YONGXIN;LIU KE;

    申请日2020-04-08

  • 分类号A61K31/365;A61K9;A61P25/02;A61P25;

  • 国家 WO

  • 入库时间 2022-08-21 11:09:03

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号